EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Anti-Inflammatory Modified Fuzi Decoction Antagonizes Synovial TNF-α/TRAF2/NF-κB Signaling to Remedy Osteoarthritis

Yue Wang iD, Jiadan Ren, Huixin Chen, Xiaotian Chen, Bo Yan, Wenting Xu, Xiujuan Xiao, Qiang Yuan, Letian Shan iD, Li Zhou iD

Drug Design, Development and Therapy · 2025-09 · Volume 19 · 7603-7621

DOI: 10.2147/dddt.s481770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-09. Verfasst von Yue Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China. Hauptthemen laut MEDLINE: Osteoarthritis, Tumor Necrosis Factor-alpha, NF-kappa B, Drugs, Chinese Herbal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisTumor Necrosis Factor-alphaNF-kappa BDrugs, Chinese HerbalTNF Receptor-Associated Factor 2Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAnimalsRats, Sprague-DawleyRatsSignal TransductionMaleArthritis, ExperimentalDose-Response Relationship, DrugDisease Models, AnimalSynovial MembraneCells, CulturedIodoacetic AcidTandem Mass SpectrometryStructure-Activity Relationship

Stichwörter der Autor:innen

TNF-α/TRAF2/NF-κB signalingmodified Fuzi decoctionnetwork pharmacologyosteoarthritissynovitis

Substanzen

Tumor Necrosis Factor-alphaNF-kappa BDrugs, Chinese HerbalTNF Receptor-Associated Factor 2Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalIodoacetic Acid

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China.
  • The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310053, People's Republic of China.
  • Fuyang Research Institute, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China.

ORCID-Profile: Yue Wang, Letian Shan, Li Zhou

Zitieren

APA

Wang, Y., Ren, J., Chen, H., Chen, X., Yan, B., Xu, W., Xiao, X., Yuan, Q., Shan, L., & Zhou, L. (2025). Anti-Inflammatory Modified Fuzi Decoction Antagonizes Synovial TNF-α/TRAF2/NF-κB Signaling to Remedy Osteoarthritis. Drug Design, Development and Therapy, Volume 19, 7603-7621. https://doi.org/10.2147/dddt.s481770

Vancouver

Wang Y, Ren J, Chen H, Chen X, Yan B, Xu W, et al. Anti-Inflammatory Modified Fuzi Decoction Antagonizes Synovial TNF-α/TRAF2/NF-κB Signaling to Remedy Osteoarthritis. Drug Design, Development and Therapy. 2025;Volume 19:7603-7621. doi:10.2147/dddt.s481770

BibTeX
@article{Wang2025,
  author = {Wang, Yue and Ren, Jiadan and Chen, Huixin and Chen, Xiaotian and Yan, Bo and Xu, Wenting and Xiao, Xiujuan and Yuan, Qiang and Shan, Letian and Zhou, Li},
  title = {Anti-Inflammatory Modified Fuzi Decoction Antagonizes Synovial TNF-α/TRAF2/NF-κB Signaling to Remedy Osteoarthritis},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {7603--7621},
  doi = {10.2147/dddt.s481770}
}
Kostenlos starten →